ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA)

Historical Holders from Q1 2014 to Q3 2025

Symbol: ENTA on Nasdaq
Type / Class: Equity / Common Stock, par value $0.01 per share
Shares outstanding: 27,767,902
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 18,990,940
Holdings value: $227,099,816
% of all portfolios: 0.001%
Number of holders: 119
Number of buys: 56
Number of sells: -52
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
JANUS HENDERSON GROUP PLC	12.1%		$41,823,994		3,494,068		JANUS HENDERSON GROUP PLC	31 Oct 2025
Farallon Capital Partners, L.P.	9.9%		$11,953,846		2,108,262		Dapice Joshua J.	31 Dec 2024
Luly Jay R.	7.7%		$9,659,503		1,703,616		Jay R. Luly, Ph.D.	12 Feb 2025
BlackRock, Inc.	7.8%		$9,488,649		1,673,483		BlackRock, Inc.	31 Mar 2025
Deep Track Capital, LP	5.33%		$17,769,621		1,484,513		Deep Track Capital, LP	02 Oct 2025
INTEGRATED CORE STRATEGIES (US) LLC	4.1%	-34.3%	$13,627,653	-$2,918,154	1,138,484	-17.6%	Millennium Management LLC	30 Sep 2025

Institutional Holders of ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	18,990,940	$227,099,816	+$9,082,734	$738,549	$3,472,497	$11.97	119
2025 Q2	18,415,589	$139,218,163	-$1,130,233	$0	$378,000	$7.56	103
2025 Q1	18,625,766	$102,810,306	-$7,313,392	$76,728	$30,912	$5.52	108
2024 Q4	19,907,432	$114,464,576	-$17,702,481	$71,300	$55,775	$5.75	105
2024 Q3	21,229,862	$219,956,486	-$10,189,778	$47,656	$49,728	$10.36	110
2024 Q2	22,131,926	$287,039,395	-$4,639,003	$29,831	$134,888	$12.97	99
2024 Q1	22,403,789	$391,166,955	+$45,279,493	$57,618	$164,124	$17.46	105
2023 Q4	20,026,111	$188,441,196	-$5,171,233	$33,876	$17,879	$9.41	103
2023 Q3	20,144,110	$225,005,701	-$8,699,698	$16,755	$8,936	$11.17	129
2023 Q2	19,936,779	$426,629,256	-$15,765,200	$19,260	$38,520	$21.4	129
2023 Q1	19,836,693	$802,018,224	+$23,678,858	$404,400	$4,100,616	$40.44	142
2022 Q4	19,243,859	$895,247,833	-$44,744,222	$162,820	$9,973,888	$46.52	145
2022 Q3	19,726,320	$1,023,129,229	-$26,641,297	$1,136,000	$9,834,000	$51.87	155
2022 Q2	20,231,748	$956,338,910	+$17,270,558	$572,000	$5,560,000	$47.27	149
2022 Q1	19,671,490	$1,399,487,075	+$60,693,984	$1,688,000	$3,937,000	$71.18	163
2021 Q4	18,780,733	$1,403,536,269	-$51,376,670	$22,404,000	$2,827,000	$74.78	172
2021 Q3	19,379,501	$1,101,045,074	+$34,578,566	$0	$2,273,000	$56.81	140
2021 Q2	18,825,846	$828,634,567	-$26,899,911	$3,235,000	$1,364,000	$44.01	147
2021 Q1	19,430,818	$956,710,887	+$7,403,943	$5,341,000	$1,968,000	$49.32	146
2020 Q4	19,261,435	$811,015,243	+$16,262,569	$3,570,000		$42.1	148
2020 Q3	18,857,563	$863,147,048	+$27,242,369	$2,105,000	$0	$45.78	170
2020 Q2	18,268,221	$917,098,781	+$10,521,228	$1,306,000	$206,000	$50.21	173
2020 Q1	18,020,619	$927,779,000	-$32,712,586	$2,936,000	$2,309,000	$51.43	154
2019 Q4	18,412,053	$1,137,352,094	+$22,036,868	$5,005,000	$5,832,000	$61.78	166
2019 Q3	17,893,697	$1,075,047,568	+$8,725,519	$6,964,000	$5,089,000	$60.08	172
2019 Q2	17,650,303	$1,489,161,032	-$2,593,033	$12,084,000	$4,506,000	$84.38	192
2019 Q1	17,808,189	$1,700,970,450	+$95,436,368	$7,459,000	$4,938,000	$95.52	195
2018 Q4	16,787,790	$1,189,003,666	+$7,018,079	$3,329,000	$4,307,000	$70.83	179
2018 Q3	16,614,214	$1,420,009,073	+$117,858,050	$3,846,000	$5,171,000	$85.46	193
2018 Q2	15,086,991	$1,748,431,673	+$46,828,949	$4,462,000	$7,824,000	$115.9	188
2018 Q1	14,743,245	$1,192,925,026	+$63,018,725	$1,205,000	$3,561,000	$80.91	177
2017 Q4	14,015,489	$822,445,465	+$75,200,938	$0	$1,139,000	$58.68	139
2017 Q3	12,779,810	$597,980,830	+$18,398,348	$426,000	$1,423,000	$46.8	122
2017 Q2	12,614,190	$453,888,968	-$5,704,439	$1,043,000	$1,264,000	$35.98	118
2017 Q1	12,846,377	$395,666,818	+$44,283,496	$1,789,000	$407,000	$30.8	123
2016 Q4	13,334,548	$446,581,457	+$14,267,822	$0	$488,000	$33.5	146
2016 Q3	13,117,480	$348,994,653	+$837,826	$221,000	$553,000	$26.61	133
2016 Q2	13,419,466	$295,897,870	-$1,389,083	$614,000	$687,000	$22.05	126
2016 Q1	14,240,811	$418,192,732	-$10,122,533	$1,988,000	$1,157,000	$29.37	150
2015 Q4	14,626,888	$483,060,372	-$20,743,890	$8,258,000	$1,017,000	$33.02	132
2015 Q3	14,924,031	$539,846,889	+$48,649,314	$734,000	$654,000	$36.14	141
2015 Q2	13,813,121	$620,989,034	+$81,244,568	$1,278,000	$1,539,000	$44.99	129
2015 Q1	12,341,155	$378,314,987	+$43,094,457	$1,151,000	$429,000	$30.62	115
2014 Q4	10,443,495	$530,912,559	+$20,770,064	$2,970,000	$1,129,000	$50.85	122
2014 Q3	10,012,073	$396,154,426	+$13,350,733	$1,607,000	$637,000	$39.57	109
2014 Q2	9,666,018	$416,088,660	+$53,128,968	$1,159,000	$909,000	$43.07	97
2014 Q1	8,437,120	$337,235,708	+$157,537,636			$39.99	79